Anti-aging medicine and science: Social implications

Handbook of Aging and the Social Sciences

Volumn , Issue , 2006, Pages 436-455

  Binstock, Robert H ^a   Fishman, Jennifer R ^a   Johnson, Thomas E ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34548653092     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088388-2/50027-4     Document Type: Chapter

References (107)

1. Achenbaum W.A. Crossing frontiers: Gerontology emerges as a science 1995, Cambridge University Press, New York.
2. A4M (American Academy of Anti-Aging Medicine) The fleecing of academic integrity by the gerontological establishment 2002, Retrieved June 13, 2002, from. http://www.worldhealth.net/html/fleecing_of_academic_integrity.htm.
3. A4M (American Academy of Anti-Aging Medicine) Official position statement on the truth about aging intervention 2002, Retrieved June 13, 2003, from. http://www.worldhealth.net/html/truth.html.
4. A4M (American Academy of Anti-Aging Medicine) The American Academy of Anti-Aging Medicine 2005, Retrieved May 31, 2005, from. http://www.worldhealth.net/p/96.html.
5. Arumainathan S. Intellectual dishonesty in geriatric medicine-truth versus fallacy: A4M sets the record straight on a campaign of disinformation challenging the facts of the science of anti-aging medicine 2001, Retrieved November 3, 2003, from. http://www.worldhealth.net/resources/IntellDishonesty.PDF.
6. Atala A. Tissue engineering and regenerative medicine: Concepts for clinical application. Rejuvenation Research 2004, 7(1):15-31.
7. Baltes P.B. On the incomplete architecture of human ontogeny: Selection, optimization, and compensation as foundation of developmental theory. American Psychologist 1997, 55:366-380.
8. Binstock R.H. The war on "anti-aging medicine". Gerontologist 2003, 43:4-14.
9. Binstock R.H. The prolonged old, the long-lived society, and the politics of age. The fountain of youth: Cultural, scientific, and ethical perspectives on biomedical goal 2004, 362-386. Oxford University Press, New York. S.G. Post, R.H. Binstock (Eds.).
10. Blackman M.R., Sorkin J.D., Munzer T., Bellantoni M.F., Busby-Whitehead J., Stevens T.E., Jayme J., O'Connor K.G., Christmas C., Tobin J.D., Steward K.J., Cottrell E., St.Clair C., Pabst K.M., Harman S.M. Growth hormone and sex steroid administration in healthy aged women and men: A randomized controlled trial. Journal of the American Medical Association 2002, 288:282-292.
11. Blumenthal H.T. The aging/disease dichotomy: True or false?. Journal of Gerontology: Medical Sciences 2003, 58A:M138-M145.
12. Bonnicksen A.L. Crafting a cloning policy: From Dolly to stem cells 2002, Georgetown University Press, Washington, DC.
13. Butler R.N. Is there an "antiaging" medicine?. Generations 2001-2002, 25(4):63-65.
14. Callahan D. Setting limits: Medical goals in an aging society 1987, Simon and Schuster, New York.
15. Callahan D. Death and the research imperative. New England Journal of Medicine 2000, 342:654-656.
16. Caplan A.L. An unnatural process: Why it is not inherently wrong to seek a cure for aging. The fountain of youth: Cultural, scientific, and ethical perspectives on a biomedical goal 2004, 271-285. Oxford University Press, New York. S.G. Post, R.H. Binstock (Eds.).
17. Carney J.M., Starke-Reed P.E., Oliver C.N., Landum R.W., Cheng M.S., Wu J.F., Floyd R.A. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butylα-phenylnitorne. Proceedings of the National Academy of Sciences USA 1991, 88:3633-3636.
18. Chan J.M., Stampfer M.J., Giovannucci E., Gann P.H., Ma J., Wilkinson P., Hennekens C.H., Pollak M. Plasma insulin-like growth factor I and prostate cancer risk: A prospective study. Science 1998, 279:563-566.
19. Chapman A.R. The social and justice implications of extending the human life span. The fountain of youth: Cultural, scientific, and ethical perspectives on a biomedical goal 2004, 340-361. Oxford University Press, New York. S.G. Post, R.H. Binstock (Eds.).
20. Chopra D. Grow younger live longer: 10 steps to reverse aging 2001, Harmony Books, New York.
21. Clarke A.E., Shim J.K., Mamo L., Fosket J.R., Fishman J.R. Biomedicalization: Technoscientific transformations of health, illness, and U.S. biomedicine. American Sociological Review 2003, 68:161-194.
22. Cole T.R., Thompson B. Anti-aging: Are you for it or against it?. Generations 2001-2002, 25(4):6-8.
23. Cozzens S.E. Autonomy and power in science. Theories of science in society 1990, 164-184. Indiana University Press, Bloomington, IN. S.E. Cozzens, T.F. Gieryn (Eds.).
24. de Grey A.D.N.J. Gerontologists and the media: The dangers of over pessimism. Biogerontology 2002, 1:369.
25. de Grey A.D.N.J., Ames B.N., Andersen J.K., Bartke A., Campisi J., Heward C.B., McCarter R.J.M., Stock G. Time to talk SENS: Critiquing the immutability of human aging. Annals of the New York Academy of Science 2002, 959:452-462.
26. de Grey A.D.N.J., Gavrilov L., Olshansky S.J., Coles L.S., Cutler R.G., Fossel M., Harman S.M. Antiaging technology and pseudoscience. Science 2002, 296:656.
27. Cyborgs and citadels: Anthropological interventions in emerging sciences, technologies and medicines 1997, School of American Research Press, Santa Fe, NM. G.L. Downey, J. Dumit, S. Traweek (Eds.).
28. Estes C.L., Binney E.A. The biomedicalization of aging: Dangers and dilemmas. Gerontologist 1989, 29:587-596.
29. FIND/SVP New anti-aging market creates opportunities for marketers 2005, Retrieved May 31, 2005 from. http://www.findsvp.com/about/2003-04.
30. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408:239-247.
31. Fisher A., Morley J.E. Antiaging medicine: The good, the bad, and the ugly. Journal of Gerontology: Medical Sciences 2002, 57A:M636-M639.
32. Fox P. From senility to Alzheimer's disease: The rise of the Alzheimer's disease movement. Milbank Quarterly 1989, 67:58-102.
33. Fries J.F. Aging, natural death and the compression of morbidity. New England Journal of Medicine 1980, 303:130-136.
34. Fukuyama F. Our posthuman future: Consequences of the biotechnology revolution 2002, Farrar, Straus & Giroux, New York.
35. Gems D. Is more life always better? The new biology of aging and the meaning of life. Hastings Center Report 2003, 33(4):31-39.
36. Gieryn T.F. Boundary-work and the demarcation of science from non-science: Strains and interests in professional ideologies of scientists. American Sociological Review 1983, 48:781-795.
37. Goldman B., Klatz R. The "E" factor: Ergogenic aids, the secrets of new-tech training and fitness for the winning edge 1988, Elite Sports Medicine Publications, Inc, Chicago.
38. Gruman G.J. A history of ideas about the prolongation of life 2003, (Original work published in 1966), Springer Publishing Company, New York.
39. Guidestar U.S. Income tax return of the American Academy of Anti-Aging Medicine for 2003, Internal Revenue Service form 990 2005, Retrieved May 26, 2005, from. http://www.guidestar.org/Documents/2003/364/087/2003-364087310.
40. Haber C. Anti-aging: Why now? A historical framework for understanding the contemporary enthusiasm. Generations 2001-2002, 25(4):9-14.
41. Hackler C. Troubling implications of doubling the lifespan. Generations 2001-2002, 25(4):15-19.
42. Hadley E.C., Lakatta E.G., Morrison-Bogorad M., Warner H.R., Hodes R.J. The future of aging therapies. Cell 2005, 120:557-567.
43. Hall S.S. Merchants of immortality: Chasing the dream of human life extension 2003, Houghton Mifflin Company, New York.
44. Harris J. Intimations of immortality. Science 2000, 288:59.
45. Hayflick L. How and why we age 1994, Ballantine Books, New York.
46. Hayflick L. "Anti-aging" is an oxymoron. Journal of Gerontology: Biological Sciences 2004, 59A:573-578.
47. Henderson S.T., Rea S.L., Johnson T.E. Dissecting the processes of aging using the nematode Caenorhabditis elegans. Handbook of the biology of aging 2006, 352-391. Academic Press, San Diego. 6th ed. E.J. Masoro, S.N. Austad (Eds.).
48. Holstein M.B. A feminist perspective on anti-aging medicine. Generations 2001-2002, 25(4):38-43.
49. Ingram D.K., Anson R.M., de Cabo R., Mamczarz J., Zhu M., Mattison J., Lane M.A., Roth G.S. Development of calorie restriction mimetics as a prolongevity strategy. Annals of the New York Academy of Science 2004, 1019:412-423.
50. Janssens H., Vanderschueren D.M.O.I. Endocrinological aspects of aging in men: Is hormone replacement of benefit?. European Journal of Obstetrics and Gynecology and Reproductive Biology 2000, 92:7-12.
51. Johnson T.E., Wu D., Tedesco P., Dames S., Vaupel J.W. Age-specific demographic profiles of longevity mutants in Caenorhabditis elegans show segmental effects. Journals of Gerontology: Biological Sciences 2001, 56A:B331-B339.
52. Johnson T.E., de Castro E., de Castro S.H., Cypser J., Henderson S., Murakami S., Rikke B., Tedesco P., Link C. Longevity genes in the nematode Caenorhabditis elegans also mediate increased resistance to stress and prevent disease. Journal of Inherited Metabolic Disease 2002, 25:197-206.
53. Juengst E.T. Anti-aging research and the limits of medicine. The fountain of youth: Cultural, scientific, and ethical perspectives on a biomedical goal 2004, 321-339. Oxford University Press, New York. S.G. Post, R.H. Binstock (Eds.).
54. Juengst E.T., Binstock R.H., Mehlman M.J., Post S.G. Antiaging research and the need for public dialogue. Science 2003, 299:1323.
55. Juengst E.T., Binstock R.H., Mehlman M.J., Post S.G., Whitehouse P.J. "Anti-aging medicine" and the challenges of human enhancement. Hastings Center Report 2003, 33(4):21-30.
56. Juengst E.T., Ponsaran R.S. Normal aging, disease prevention, and medical ethics. Public Policy & Aging Report 2004, 14(2):14-18.
57. Kass L.R. L'chaim and its limits. Why not immortality?. First Things 2001, 13:17-24.
58. Kass L.R. Ageless bodies, happy souls. The New Atlantis 2003, (1):9-28.
59. Ten weeks to a younger you 1999, Sport Tech Labs, Inc., Chicago. R. Klatz (Ed.).
60. Lockett B.A. Aging, politics, and research: Setting the federal agenda for research on aging 1983, Springer Publishing Company, New York.
61. Longo V.D., Finch C.E. Evolutionary medicine: From dwarf model systems to healthy centenarians?. Science 2003, 299:1342-1346.
62. Mair W., Goymer P., Pletcher S.D., Partridge L. Demography of dietary restriction and death in Drosophila. Science 2003, 301:1731-1733.
63. Caloric restriction's effects on aging: Opportunities for research on human implications. Journal of Gerontology: Biological Sciences 2001, 56A.
64. Masoro E.J. Caloric restriction: A key to understanding and modulating aging 2002, Elsevier Science, Amsterdam.
65. Masoro E.J., Austad S.N. Handbook of the biology of aging 2006, Academic Press, San Diego. 6th ed.
66. Mehlman M.J., Binstock R.H., Juengst E.T., Ponsaran R.S., Whitehouse P.J. Gerontologist 2004 Anti-aging medicine: Can consumers be better protected?, 44:304-310.
67. Miller R.A. Extending life: Scientific prospects and political obstacles. Milbank Quarterly 2002, 80:155-174.
68. Moody H.R. Who's afraid of life extension?. Generations 2001-2002, 25(4):33-37.
69. NIA (National Institute on Aging) Media campaign cautions consumers about "anti-aging" hormone supplements 1997, [NIH news release April 1.] Retrieved July 3, 2002, from. http://www.nia.nih.gov/news/pr/1997/04%2D01.htm.
70. NIA (National Institute on Aging) Action plan for aging research: Strategic plan for fiscal years 2001-2005 2001, Retrieved May 31, 2005, from. http://www.nia.nih.gov/AboutNIA/StrategicPlan/ResearchGoalB/Subgoal1.htm .
71. NIA (National Institute on Aging) Life-extension. Science or science fiction? 2002, Retrieved July 8, 2002, from. http://www.nia.nih.gov/health/agepages/lifeext/htm.
72. NIA (National Institute on Aging) Looking for the fountain of youth? 2002, Retrieved July 3, 2002, from. http://www.nia.nih.gov/Health/ads/fountl.git.
73. NIA (National Institute on Aging) Resource directory for older people 2005, Retrieved May 26, 2005 from. http://www.nia.nih.gov/HealthInformation/ResourceDirectory.htm.
74. Oeppen J., Vaupel J.W. Broken limits to life expectancy. Science 2002, 296:1029-1031.
75. Olshansky S.J., Carnes B.A. The quest for immortality: Science at the frontiers of aging 2001, W. W. Norton, New York.
76. Olshansky S.J., Hayflick L., Carnes B.A. No truth to the fountain of youth. Scientific American 2002, 286(6):92-95.
77. Olshansky J.S., Hayflick L., Carnes B.A. Position statement on human aging. Journal of Gerontology: Biological Sciences 2002, 57A:B292-B297.
78. Anti-aging medicine: The hype and the reality. Journal of Gerontology: biological Sciences (special publication) 2004, The Gerontological Society of America, Washington, DC. J.S. Olshansky, L. Hayflick, T.T. Perls (Eds.).
79. Overall C. Aging, death, and human longevity: A philosophical inquiry 2003, University of California Press, Berkley, CA.
80. Parker J.A., Arango M., Abderrahmane S., Lambert E., Tourette C., Catoire H., Neri C. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nature Genetics 2005, 37:349-350.
81. Perls T.T. Anti-aging quackery: Human growth hormone and tricks of the trade-more dangerous than ever. Journal of Gerontology: Biological Sciences 2004, 59A:682-691.
82. Pollack A. Forget Botox. Anti aging pills may be next. New York Times, Section 3 2003, September 21, 1.
83. Pollack A. Forget Botox. Anti aging pills may be next. New York Times, Section 3 2003, September 21, 10.
84. Pope E. 51 top scientists blast antiaging idea. AARP Bulletin 2002, 23(43):3-5.
85. Post S.G. Establishing an appropriate ethical framework: The moral conversation around the goal of prolongevity. Journal of Gerontology: Biological Sciences 2004, 59A:B534-B539.
86. The fountain of youth: Cultural, scientific, and ethical perspectives on a biomedical goal 2004, Oxford University Press, New York. S.G. Post, R.H. Binstock (Eds.).
87. President's Council on Bioethics Beyond therapy: Biotechnology and the pursuit of happiness 2003, Harper Collins Publishers, New York.
88. Rikke B.A., Yerg J.E., Battaglia M.E., Nagy T.R., Allison D.B., Johnson T.E. Quantitative trait loci specifying the response of body temperature to dietary restriction. Journal of Gerontology: Biological Sciences 2004, 59A:B118-B125.
89. Robert L.L. The three avenues of gerontology: From basic research to clinical gerontology and anti-aging medicine. Another French paradox. Journal of Gerontology: Biological Sciences 2004, 59A:540-542.
90. Robinson J. Noble conspirator: Florence S. Mahoney and the rise of the National Institutes of Health 2001, The Francis Press, Washington, DC.
91. Roth G.S., Mattison J.A., Ottinger M.A., Chachich M.E., Lane M.A., Ingram D.K. Aging in rhesus monkeys: Relevance to human health interventions. Science 2004, 305:1423-1426.
92. Science of Aging Knowledge Environment Genes/interventions (database) 2005, Retrieved April 30, 2005 from. http://sageke.sciencemag.org/cgi/genesdb.
93. The impact of increased life expectancy: Beyond the gray horizon 1995, Springer Publishing Company, New York. M.M. Seltzer (Ed.).
94. Sinclair D. Sirtuins for healthy neurons. Nature Genetics 2005, 37:339-340.
95. Stock S., Callahan D. Point-counterpoint: Would doubling the human life span be a net positive or negative for us either as individuals or as a society?. Journal of Gerontology: Biological Sciences 2004, 59A:B554-B559.
96. Swift J. Gulliver's travels 1991, (Original work published in 1726), Knopf Everyman's Library, New York.
97. Tatar M., Bartke A., Antebi A. The endocrine regulation of aging by insulin-like signals. Science 2003, 299:1346-1351.
98. Taylor C.A. Defining science: A rhetoric of demarcation 1996, University of Wisconsin Press, Madison, WI.
99. U.S.GAO (General Accounting Office) Health products for seniors: "Antiaging" products pose potential for physical and economic harm. GAO-01-1129 2001, U.S. Government Printing Office, Washington, DC.
100. U.S.Senate Special Committee on Aging Swindlers, hucksters and snake oil salesmen: The hype and hope of marketing anti-aging products to seniors 2001, September 10, Hearing held in Washington, DC.
101. University of Illinois at Chicago Silver Fleece Awards target anti-aging hype. [Office of Public Affairs, News Release, February 12.] 2002, Retrieved June 21, 2002, from. http://tigger.uic.edu/htbin/cgiwrap/bin/newsbureau.
102. Vance M.L. Can growth hormone prevent aging?. New England Journal of Medicine 2003, 348:779-780.
103. Warner H.L., Ingram D., Miller R.A., Nadon N.L., Richardson A.G. Program for testing biological interventions to promote healthy aging. Mechanisms of Ageing and Development 2000, 115:199-208.
104. Weiner H.L., Selkoe D.J. Inflammation and therapeutic vaccination in CNS diseases. Nature 2002, 420:879-884.
105. Wick G. Anti-aging medicine: Does it exist? A critical discussion of anti-aging health products. Experimental Gerontology 2002, 37:1137-1140.
106. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 2002, 288:321-333. Writing Group for the Women's Health Initiative Investigators.
107. Youngevity Youngevity product highlights 2005, Retrieved May 29, 2005, from. http://youngevity.com/brochure/brochure_pl.htm.